S&W Seed (SANW) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for S&W Seed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SANW shares.
View SANW analyst ratings or view top-rated stocks.

1 brokers have issued twelve-month price targets for S&W Seed's stock. Their SANW share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 178.2% from the stock's current price.
View analysts price targets for SANW or view top-rated stocks among Wall Street analysts.

S&W Seed's stock was trading at $1.49 at the beginning of the year. Since then, SANW shares have decreased by 27.6% and is now trading at $1.0782.
View the best growth stocks for 2023 here.

S&W Seed saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 45,400 shares, an increase of 29.0% from the April 30th total of 35,200 shares. Based on an average daily trading volume, of 40,200 shares, the days-to-cover ratio is presently 1.1 days.
View S&W Seed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 27th 2023.
View our SANW earnings forecast.

S&W Seed (NASDAQ:SANW) released its quarterly earnings results on Monday, February, 13th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The business had revenue of $12.94 million for the quarter, compared to analyst estimates of $11.80 million. S&W Seed had a negative trailing twelve-month return on equity of 43.78% and a net margin of 12.39%. During the same quarter in the prior year, the firm posted ($0.26) EPS.

S&W Seed updated its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65.00 million-$75.00 million, compared to the consensus revenue estimate of $88.30 million.

2 employees have rated S&W Seed Chief Executive Officer Mark S. Grewal on Glassdoor.com. Mark S. Grewal has an approval rating of 100% among the company's employees. This puts Mark S. Grewal in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other S&W Seed investors own include Viking Therapeutics (VKTX), Viveve Medical (VIVE), QUALCOMM (QCOM), AT&T (T), Ampio Pharmaceuticals (AMPE), Amyris (AMRS), Enphase Energy (ENPH), Ford Motor (F) and Micron Technology (MU).

S&W Seed trades on the NASDAQ under the ticker symbol "SANW."

S&W Seed's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cutter & CO Brokerage Inc. (4.85%), Essex Investment Management Co. LLC (1.14%), Thompson Davis & CO. Inc. (0.94%), Geode Capital Management LLC (0.41%), Shufro Rose & Co. LLC (0.38%) and Oak Family Advisors LLC (0.34%). Insiders that own company stock include Alan D Willits, Mark Wong, Mfp Partners Lp and Wynnefield Partners Small Cap.
View institutional ownership trends.

Shares of SANW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SANW stock can currently be purchased for approximately $1.08.

S&W Seed (NASDAQ:SANW) has a market capitalization of $46.32 million and generates $71.35 million in revenue each year. The company earns $-36,400,000.00 in net income (profit) each year or $0.18 on an earnings per share basis.

The company employs 171 workers across the globe.

S&W Seed's mailing address is 2101 Ken Pratt Blvd Suite 201, Longmont CO, 80501. The official website for the company is www.swseedco.com. The company can be reached via phone at (720) 506-9191, via email at sanw@lythampartners.com, or via fax at 559-884-2750.